Bio Path | BPTH - Pre Tax Profit

Stock Price
0.07
Daily Change
-0.001 -1.97%
Monthly
25.24%
Yearly
-67.56%
Q1 Forecast
0.06

Bio Path reported $-2.85M in Pre-Tax Profit for its fiscal quarter ending in March of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Baxter International USD 121M 12M Sep/2025
Bio Path USD -2.85M 99K Mar/2025
Cipla INR 11.69B 6.85B Dec/2025
Clal Biotechnology ILS 86.82M 17.9M Dec/2022
Compugen USD -6.94M 421K Sep/2025
CSL USD 1.4B 1.14B Jun/2025
Grifols EUR 66.98M 19.92M Jun/2024
Karyopharm Therapeutics USD -30.89M 1.16M Dec/2024